Real-world outcomes of ranibizumab in patients with retinal vein occlusion from the LUMINOUS™ study

被引:0
|
作者
Pearce, Ian [1 ]
Parikh, Soumil [2 ]
Macfadden, Wayne [2 ]
机构
[1] Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool, Merseyside, England
[2] Novartis Pharma AG, Basel, Switzerland
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
2566
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Efficacy of Dexamethasone Intravitreal Implant Compared with Intravitreal Ranibizumab in Patients with Central Retinal Vein Occlusion and Branch Retinal Vein Occlusion
    Aydin, Erdinc
    Gurakar, Seda
    Egrilmez, Emine Deniz
    OPHTHALMOLOGICA, 2014, 232 : 87 - 87
  • [42] An analysis of ranibizumab treatment and visual outcomes in real-world settings: the UNCOVER study
    Eldem, Bora
    Lai, Timothy Y. Y.
    Ngah, Nor Fariza
    Vote, Brendan
    Yu, Hyeong Gon
    Fabre, Alban
    Backer, Arthur
    Clunas, Nathan J.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 256 (05) : 963 - 973
  • [43] Long-term Outcomes in Ranibizumab-Treated Patients With Retinal Vein Occlusion; The Role of Progression of Retinal Nonperfusion
    Sophie, Raafay
    Hafiz, Gulnar
    Scott, Adrienne W.
    Zimmer-Galler, Ingrid
    Quan Dong Nguyen
    Ying, Howard
    Do, Diana V.
    Solomon, Sharon
    Sodhi, Akrit
    Gehlbach, Peter
    Duh, Elia
    Baranano, David
    Campochiaro, Peter A.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2013, 156 (04) : 693 - 705
  • [44] Real-world treatment patterns for macular edema secondary to retinal vein occlusion in the United States
    Chi, Gloria
    Haskova, Zdenka
    Chuo, Ching-Yi
    Chang, Shih-Chen
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [45] An analysis of ranibizumab treatment and visual outcomes in real-world settings: the UNCOVER study
    Bora Eldem
    Timothy Y. Y. Lai
    Nor Fariza Ngah
    Brendan Vote
    Hyeong Gon Yu
    Alban Fabre
    Arthur Backer
    Nathan J. Clunas
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2018, 256 : 963 - 973
  • [46] REAL-WORLD EFFECTIVENESS AND SAFETY OF RANIBIZUMAB TREATMENT IN PATIENTS WITH AND WITHOUT POLYPOIDAL CHOROIDAL VASCULOPATHY Twelve-Month Results From the LUMINOUS Study
    Koh, Adrian
    Lai, Timothy Y. Y.
    Wei, Wen Bin
    Mori, Ryusaburo
    Wakiyama, Harumi
    Park, Kyu Hyung
    Ngah, Fariza
    Macfadden, Wayne
    Dunger-Baldauf, Cornelia
    Parikh, Soumil
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2020, 40 (08): : 1529 - 1539
  • [47] Real-world outcomes of anti-vascular endothelial growth factor therapy for retinal vascular vein occlusion in Tibet, China
    Zhu, Xue-Mei
    Yu, Ying-Ying
    Zhuoga, Sina
    Dawa, Xiao
    Zhou, Yong-Kang
    Wangmu, Ouzhu
    Yangzong, Deji
    An, Fang
    Miao, Heng
    Zhao, Ming -Wei
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2022, 15 (11) : 1814 - 1820
  • [48] Real-world outcomes of intravitreal bevacizumab treat-and-extend for cystoid macular oedema secondary to central retinal vein occlusion
    David Gildea
    Bobby Tang
    Caroline Baily
    Andrea Ryan
    International Ophthalmology, 2023, 43 : 4105 - 4110
  • [49] Real-World Data on Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 24-Month Outcomes
    Shimura, Masahiko
    Fukumatsu, Makoto
    Tsujimura, Jun
    Hirano, Kazufumi
    Sunaya, Toshiyuki
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 579 - 592
  • [50] Real-world outcomes of anti-vascular endothelial growth factor therapy for retinal vascular vein occlusion in Tibet,China
    Xue-Mei Zhu
    Ying-Ying Yu
    Sina Zhuoga
    Xiao Dawa
    Yong-Kang Zhou
    Ouzhu Wangmu
    Deji Yangzong
    Fang An
    Heng Miao
    Ming-Wei Zhao
    International Journal of Ophthalmology, 2022, 15 (11) : 1814 - 1820